Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linqi Zhang

Showing results (261-270 of 279) with videos related to

Pageof 28
Sort By:
Cell Research|March 18, 2021
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodiesRenhong Yan, Ruoke Wang, Bin Ju, et al.
Ebiomedicine|September 4, 2019
Forecasting influenza activity using self-adaptive AI model and multi-source data in Chongqing, ChinaKun Su, Liang Xu, Guanqiao Li, et al.
Cell|March 18, 2021
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escapeQianqian Li, Jianhui Nie, Jiajing Wu, et al.
Iscience|March 16, 2022
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variantsQingtai Liang, Yifeng Wang, Shuyuan Zhang, et al.
Nature Communications|December 5, 2024
Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodiesXuanyu Nan, Yujie Li, Rui Zhang, et al.
Nature Communications|December 27, 2022
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecovirusesMingxi Li, Yifei Ren, Zhen Qin Aw, et al.
Nature Communications|August 13, 2024
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alterationLinjing Zhu, Bilian Huang, Xiangyao Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2025
Organoid-based neutralization assays reveal a distinctive profile of SARS-CoV-2 antibodies and recapitulate the real-world efficacyZhixin Wan, Cun Li, Ying Zhou, et al.
Chemistry & Biology|September 24, 2004
Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical geneticsRichard Y Kao, Wayne H W Tsui, Terri S W Lee, et al.
Nature|July 23, 2020
Structural basis of GPBAR activation and bile acid recognitionFan Yang, Chunyou Mao, Lulu Guo, et al.
Pageof 28

Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Cell Research|March 18, 2021
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodiesRenhong Yan, Ruoke Wang, Bin Ju, et al.
Ebiomedicine|September 4, 2019
Forecasting influenza activity using self-adaptive AI model and multi-source data in Chongqing, ChinaKun Su, Liang Xu, Guanqiao Li, et al.
Cell|March 18, 2021
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escapeQianqian Li, Jianhui Nie, Jiajing Wu, et al.
Iscience|March 16, 2022
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variantsQingtai Liang, Yifeng Wang, Shuyuan Zhang, et al.
Nature Communications|December 5, 2024
Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodiesXuanyu Nan, Yujie Li, Rui Zhang, et al.
Nature Communications|December 27, 2022
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecovirusesMingxi Li, Yifei Ren, Zhen Qin Aw, et al.
Nature Communications|August 13, 2024
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alterationLinjing Zhu, Bilian Huang, Xiangyao Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2025
Organoid-based neutralization assays reveal a distinctive profile of SARS-CoV-2 antibodies and recapitulate the real-world efficacyZhixin Wan, Cun Li, Ying Zhou, et al.
Chemistry & Biology|September 24, 2004
Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical geneticsRichard Y Kao, Wayne H W Tsui, Terri S W Lee, et al.
Nature|July 23, 2020
Structural basis of GPBAR activation and bile acid recognitionFan Yang, Chunyou Mao, Lulu Guo, et al.
Pageof 28